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Background: The Luo community of Kenya rely mostly on ethno-medicine to manage human ailments. This study 
was set to survey, record and report the medicinal plant species they use to manage infectious conditions.  
Objective of this study was to screen the plants used by this community to treat microbial infections, to demonstrate 
their in-vitro antibacterial and antifungal activities.  
Methodology: Eight plants namely Lannea stuhlmanii, Carissa edulis, Combretum fragrans, Conyza sumatrensis, 
Ormocarpum trichocarpum, Sida cuneifolia, Plumbago zeylanica, and Rhoicissus revoilii, used by the Luo for treatment 
of microbial infections, were studied. Observations and semi-structured interviews were used to gather ethno-
botanical data for each plant. About 3 kg of suitable specimens were harvested, with leaves pressed and preserved for 
identification at University of Nairobi’s Department of Botany Herbarium. Voucher specimens were also deposited at 
the University’s School of Pharmacy Herbarium and excess material powdered and kept dry. The pressed specimens 
were dried at 20 0C to 25 0C using plant blower. Their ethanolic extracts were screened for their antimicrobial activity 
against Candida albicans, Escherichia coli, Staphylococcus aureus and Bacillus pumulus.  
Results: Extracts from Conyza sumatrensis, C. fragrans, C. edulis, S. cuneifolia, R. revoilii and leaf C. sumatrensis had 
good activity against E. coli. Activity against B. pumulus was observed in all extracts except those of L. stuhlmanii bark 
and R. revoilii tubers. Good activity against S. aureus was observed with C. fragrans, S. cuneifolia and L. stuhlmanii. 
Rhoicissus revoilii, L. stuhlmanii, C. fragrans and C. edulis exhibited good antifungal activity against Candida albicans. 
Conclusion: This work partially supports the traditional antimicrobial use of the various plants, and it is hoped that 
the results will form the basis for further research that could lead to isolation and/or development of antibacterial 
and antifungal medicines for use in primary health care. The results also confirm that plants are a potential source of 
antimicrobial compounds.  
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1. Introduction 
The Luo community of Kenya have traditionally used 
plants to treat diseases of microbial origin. These plants 
include Lannea stuhlmanii, Carrisa edulis, Combretum 
fragrans, Conyza sumatrensis, Ormocarpum 
trichocarpun, Sida cuneifolia, Plumbago zeylanica and 
Rhoicissus revoilii. Lannea stuhlmanii Engl bark is 
usually mixed with R. revoilii, boiled and the decoction 
taken to treat pneumonia, diarrhoea and giardiasis. 
Carrisa edulis Forsk roots are mixed with Ximenia 
americana L. and E. divinorum then boiled and their 
decoction taken to treat gonorrhoea, boils and 
indigestion. Combretum fragrans F. Hoffm roots and 
bark are ground and extracted with warm water. This 
extract is used to treat typhoid and diarrhoea. Conyza 
sumatrensis leaves are dried and ground to make a 
cream or ointment which is used to treat pimples, tinea 
versicolor and tonsillitis. Sida cuneifolia Roxb leaves are 
dried and ground to a powder. This powder is applied 
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to cuts, wounds and tropical ulcers. Ormocarpum 
trichocarpum Hiern whole plant is powdered and 
formulated to a cream or ointment which is used to 
manage primary syphilitic sores (Obua et al, 2002; 
Eyhrquist et al, 2002; Kokwaro, 1976; Yenjai et al, 2004; 
Eloff, 1998; Ramezani, 2004; Setzer et al, 2004; 
Hoffman, 2004; Camporese et al, 2003; Goskel, 2003; 
Olivia et al, 2003; Mwangi et al, 2002). 
The aim of the study was to screen these plants to 
demonstrate their in-vitro antibacterial and antifungal 
activities which can validate their traditional uses. 
2. Materials and Methods 
2.1 Plant collection, preservation and extraction 
About 10 kg of the plants used in this study were 
collected from Rarieda, Bondo District, of Nyanza 
Province in Kenya, in October 2004. Plant identification 
was done at the Department of Botany Herbarium, 
University of Nairobi and voucher specimen deposited 
in the same herbarium. The plant material was oven 
dried at 45 °C, powdered and kept dry at room 
temperature until use.  
2.2 Extraction procedure 
About 25 g of each plant powder was weighed and 
extracted with 0.5 l ethanol for 3 hr by constantly 
stirring with a magnetic stirrer. The extract was filtered 
through filter paper and reduced in vacuo to dryness. 
The extract was then stored at 2-8 °C until used.  
2.2 Culturing of test microorganisms 
The fungus used was Candida albicans HG 392, while 
bacteria used were Escherichia coli NCTC 10418, 
Staphylococcus aureus NCTC 6571 and Bacillus pumulus 
NCTC 10073. 
Standardised cultures of bacteria and fungi were sub-
cultured overnight then harvested with 5 ml saline 
solution. The bacteria were sub cultured in tryptone 
soya agar (TSA) (12.2 g agar made to 100 ml in distilled 
water), while C. albicans was sub-cultured in 
Sabouraud’s dextrose agar (SDA, i.e. 6.6 g agar made to 
100 ml in distilled water). The two culture media 
solutions were sterilized at 121 °C for 15 min then 
allowed to cool in the laminar flow hood to 50 °C. The 
TSA solution was divided into three fractions of 100 ml 
for each organism. To each was added the harvested 
bacterial suspension. To the SDA solution was added 
the Candida suspension.  
2.3 Testing for anti-microbial activity  
The suspensions were plated out, 20 ml per plate and 
left to set. Reservoir wells (diameter 8 mm) of about 50 
µl were then punched (6 per plate) at equal spacing 
round the circumference of the seeded agar. To each 
well was added 50 µl of test solution, each solution 
being in duplicate for each organism. The plates were 
incubated for about 20 hr after which the zones of 
inhibition (exhibition) were read. There was negative 
control using zero-dose preparation.  
Agar diffusion assay method was used for both fungi 
and bacteria (Hugo and Russel, 1987; Hewit and 
Vincent, 1989). Standard concentrations of known 
antimicrobial agents (0.12 mg/ml nystatin and 0.3 
mg/ml chloramphenicol) were used as positive 
controls. 
Antimicrobial screening was done in duplicate for each 
plant specimen. About 500 mg of the ethanolic extract 
of each plant was triturated with 1 ml DMSO then made 
up to 5 ml in distilled water to give a test solution of 100 
µg/µl concentration for each fraction. To each well was 
added 50 µl, giving a total of 5000 µg of extract per well. 
 
Table 1: Zones of inhibition (in mm) of ethanol extracts against C. albicans, E. coli, Staph. aureus and B. pumulus 









Conyza sumatrensis Leaves 9.8 13.96 a 0 16.78 a 
Conyza sumatrensis Roots 9.6 26.85 a 0 27.84 a 
Combretum fragrans Bark 20.0 13.78 14.51 14.41 
Carrisa edulis Roots 19.3 20.22 a 13.17 a 18.67 a 
Sida cuneifolia Whole 12.9 21.36 a 14.14 a 21.11 a 
Lannea stuhlmanii Bark 18.5 11.31 15.30 13.93 
Rhoicissus revoilii Rhizomes 17.5 12.82 12.50 12.18 
Plumbago zeylanica Whole 14.2 0 0 16.22 a 
Nystatin 0.12 µg/µl in water  21.1 - - - 
Chloramphenicol 0.3 µg/µl in 
water 
 - 13.67 20.76 15.80 
Dimethylsuphoxide (DMSO)  0 0 0 0 
 All readings are means of duplicates. All extracts used at a concentration of 100 µg /µl.  
 a: Zones of exhibition (growth enhancement).   
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Table 2: Zones of inhibition (mm) of Combretum fragrans extracts against Escherichia coli and Bacillus pumilus 
Sample 
Zone of inhibition in 
Escherichia coli (mm) 
Zone of inhibition in 
Bacillus pumulus (mm) 
Methanol Extract 13.01 14.49 
Chloroform Extract 9.11 7.34 
Ethanol extract 18.25 17.71 
Ethyl acetate partition of ethanol extract 11.47 10.25 
Chloramphenicol 0.3 µg/µl in water 21.12 21.04 
Dimethylsuphoxide (DMSO) None None 
  All readings are means of duplicates. All extracts used at a concentration of 100 µg /µl. 
 
3.  Results 
Zones of inhibition readings (in mm) for Candida 
albicans, Escherichia coli, Staphylococcus aureus and 
Bacillus pumulus for the test solutions of all the 
specimen were recorded as in Table 1. 
From the results, it was observed that C. fragrans bark 
ethanol extract had the highest and broadest 
antimicrobial activity. Combretum fragrans, C. edulis, L. 
sthlmanii and R. revoilii extracts (100 µg/ µl) had very 
satisfactory anti-fungal activity, comparable with that of 
the standard drug (Nystatin 0.12 µg/µl in water) while 
those of S. cuneifolia and P. zeylanica had fair activity. C. 
sumatrensis had the lowest activity. Against E. coli, C. 
sumatrensis, C. edulis and S. cuneifolia enhanced growth. 
C. fragrans had better inhibitory activity than the 
standard drug. L. stuhlmanii and R. revoilii had fair 
activity while P. zeylanica had no activity at all. 
Against S. Aureus; C. fragrans and L. stuhlmanii had good 
inhibitory activity, R. revoilii had fair activity, C. 
sumatrensis and P. zeylanica had no activity, while C. 
edulis and S. cuneifolia enhanced growth. Against B. 
Pumulus; C. sumatrensis, C. edulis, P. zeylanica and S. 
cuneifolia all had exhibitory activity.  Compared with 
the standard, C. fragrans, L. stuhlmanii and R. revoilii 
had favourable inhibitory activity.  
Combretum fragrans was selected for further study. The 
results of bacterial growth inhibition (Table 2) showed 
the highest inhibition with the ethanol extract, followed 
by the methanol, ethyl acetate and chloroform extracts. 
The antimicrobial activity of the ethanol extract 
compared well with the activity of chloramphenicol 
standard. This means the antimicrobial compound(s) in 
C. fragrans bark powder are fairly polar. However, the 
methanol, ethanol, ethyl acetate and acetone extracts of 
C. fragrans all formed dark brown insoluble precipitates 
on exposure to heat and light, making further work on 
them impossible under the circumstances. The 
chloroform extract was chosen for further evaluation. 
4. Discussion 
These results compare very well with the known 
antimicrobial activities of methanol extracts of 
Artemesia species of Iran (Ramezani et al, 2004) and 
Terminalia chebula (Shahidi, 2004a; Shahidi, 2004b) 
both of the Combretaceae family. 
Of the 8 plants specimen studied, good justification was 
found for the use of R. revoilii, L. stuhlmanii, C. fragrans 
and C. edulis in fungal infections caused by Candida 
albicans. Although the use of P. zeylanica in the 
treatment of tonsillitis and pharyngitis by chewing has 
not been validated through this work, the uses of the 
other listed plants by the Luo community seem very 
reasonable. This work has, especially, validated the use 
of a mixture of L. stuhlmanii and R. revoilii (in the 
treatment of diarrhoea and bacterial pneumonia), C. 
sumatrensis (in pimples, tinea versicolor and tonsillitis), 
R. revoilii (in tonsillitis) and C. sumatrensis (in cuts, 
wounds, tropical ulcers and sore throat).  
S. cuneifolia and C. edulis enhanced bacterial growth 
generally. This is possibly because they contain 
significant amounts of nutrients like amino acids and, 
especially, vitamins. Could they have found use in 
traditional medicine because of this, or do they enhance 
immunity? These are questions that need further 
research to answer. C. edulis is traditionally used in 
conjunction with other herbs, which may have anti-
microbial activity. However, S. cuneifolia is used alone, 
as powder, applied on wounds. This is potentially 
dangerous.                     
Different C. fragrans extracts were screened for their 
antibacterial activity against Escherichia coli and 
Bacillus pumulus. Ethanol extract showed the highest 
activity, followed by the methanol extract, ethyl acetate 
extract and chloroform extract, in that order.  
The results from this study partially support the 
traditional antimicrobial use of C. fragrans, and it is 
hoped that the results will form the basis for further 
research that could lead to isolation and/or 
development of antibacterial and antifungal medicines 
for use in primary health care. The results also confirm 
that plants are a potential source of antimicrobial 
compounds. 
Conflict of Interest declaration 
The authors declare no conflict of interest.  
 Maima et al, Afr. J. Pharmacol. Ther. 2014. 3(4): 112-115 
 
A KeSoBAP Publication ©2014. All rights reserved.  ISSN 2303-9841 
115 
Acknowledgements 
The authors are grateful to the Deans Committee, 
University of Nairobi, for funding this study (Grant No. 
500 - 655 - 499), Dr. H. Chepkwony of National Quality 
Control Laboratory for allowing us to use their 
laboratory facilities, the late Joan Dina Awuor (Nyar 




Camporese A, Balick MJ, Arvigo R, Esposito RG, Morsellino N, 
Simone FD, and  Tubaro A (2003). Screening of anti-bacterial 
activity of medicinal plants from Belize (Central America). J. 
Ethnopharmacol. 87: 103-107. 
Eloff JN (1998). Which extractant should be used for the 
screening and isolation of antimicrobial components from 
plants?  J. Ethnopharmacol. 60: 1-8 
Eyhrquist P, Mwasumbi L, Haeggstrom CA, Vuorela H, 
Hiltunen R, and Vuorela P (2002). J. Ethnopharmacol. 79: 169-
77. 
Goksel K (2003). The antimicrobial activity of essential oils of 
Hypericum scabrum, Hypericum scabroides and Hypericum 
triquetrifolium. Phytother. Res. 18: 339-341. 
Hewit W, and Vincent S (1989). Theory and Application of 
Microbiological Assay, Academic Press Inc., San Diego, USA. 
Pp. 4-6, 10, 14, 72. 
Hoffman BR (2004). Screening of antibacterial and antifungal 
activities of ten medicinal plants from Ghana, Pharmaceutical 
Biology. Int. J. Pharmacogn. 42: 13-17. 
Hugo WB, Russell AD, Eds (1987). Pharmaceutical 
Microbiology 4th Edition, Blackwell Scientific Publications, 
London, UK. Pp. 163-170, 204-214. 
Kokwaro JO (1976). Medicinal Plants of East Africa, East 
African Literature Bureau, Nairobi, Kenya. Pp 17, 22-26, 36, 
58, 64-67, 85, 122-129, 156, 177, 203-227, 251-280. 
Mwangi JW, Thoithi GN, Kibwage IO, Zygadlo JA, Lopez ML, 
Olivia MM, Demo MS, Toyota M and Chalchat JC (2001). 
Constituents of the essential oil of Cymbopogon afronardus 
Stapf. East Cent. Afr. J. Pharm. Sci. 4: 43-47. 
Obua C, Odyek O, Anokbonggo WW, Apio SK, Waako P, and 
Ogwal-Okeng JW (2002). East Cent. Afr. J. Pharm. Sci. 5: 33-37. 
Olivia MM, Demo MS, Malele RS, Mutayabarwa CK, Mwangi JW, 
Thoithi GN, Kibwage IO, Faillaci SM, Scrivanti RL, Lopez AG 
and Zygadlo JA (2003). Essential oil of Brachylaena hutchinsii 
Hutch from Tanzania: Antimicrobial activity and composition. 
East Cent. Afr. J. Pharm. Sci. 6: 61-63. 
Ramezani M, Fazli-Bazzaz BS, Saghafi-Khadem F, and 
Dabaghian A (2004). Antimicrobial activity of four Artemesia 
species of Iran, Fitoterapia 75: 201-203. 
Setzer WN, Vogler B, Schmidt JM, Leahy JG, and Rives R 
(2004). Antimicrobial Activity of Artemisia douglasiana leaf 
essential oil. Fitoterapia 75: 192-200. 
Shahidi G, and Bonjar H (2004). Inhibition of clotrimazole–
resistant Candida albicans by plants used in Iranian folkloric 
medicine, Fitoterapia 75: 74 -76. 
Shahidi, G, and Bonjar H (2004). Antibacterial screening of 
plants used in Iranian folkloric medicine, Fitoterapia 75: 231-
235. 
Yenjai C,  Prasanphen K, Daodee S, Wongpanich V, and 
Kittakoop P. (2004). Bioactive flavonoids from Kaempferia 
parviflora. Fitoterapia 75: 89-92. 
 
 
